A new multi-center study led by doctors at Boston Medical Center and Columbia University found that having a genetic variant in the prealbumin gene alone is not sufficient for diagnosis of transthyretin amyloid cardiomyopathy in older Black patients.
Breaking: Lykos Therapeutics Moved to Patent MDMA In Late 2022, Filing Reveals – Psychedelic Alpha
While obtaining a patent on the drug itself might be tricky—Merck had patented MDMA over a hundred years ago in 1912 after it found it